-
-
-
-
-
-
-
Oppenheimer Upgrades Korro Bio Inc. (KRRO) to Outperform
-
-
-
-
-
-
-
H.C. Wainwright Downgrades Korro Bio Inc. (KRRO) to Neutral
-
-
-
-
-
-
-
Korro Bio reports mixed results from KRRO-110 trial, cuts workforce by third
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Korro Bio Inc. (KRRO)
-
-
-
-
-
-
-
Korro Bio (KRRO) Appoints Loïc Vincent as Chief Scientific Officer
-
-
-
-
-
-
-
Korro Bio (KRRO) Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Korro Bio Inc. (KRRO)
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

